Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News EC approves Reblozyl for transfusion-dependent anemia in adults Bristol Myers Squibb and Acceleron Pharma have secured approval from the European Commission (EC) for their jointly developed… bypharmanewsdailyJune 28, 2020